European low-dose radiation risk research strategy: Future of research on biological effects at lowdoses

Sisko Salomaa*, Dietrich Averbeck, Andrea Ottolenghi, Laure Sabatier, Simon Bouffler, Michael Atkinson, Jean René Jourdain

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)

Abstract

In 2009, the European High Level and Expert Group identified key policy and scientific questions to be addressed through a strategic research agenda for low-dose radiation risk. This initiated the establishment of a European Research Platform, called MELODI (Multidisciplinary European Low Dose Research Initiative). In 2010, the DoReMi Network of Excellence was launched in the Euratom 7th Framework Programme. DoReMi has acted as an operational tool for the sustained development of the MELODI platform during its early years. A long-term Strategic Research Agenda for European low-dose radiation risk research has been developed by MELODI. Strategic planning of DoReMi research activities is carried out in close collaboration with MELODI. The research priorities for DoReMi are designed to focus on objectives that are achievable within the 6-y lifetime of the project and that are in areas where stimulus and support can help progress towards the longer-term strategic objectives.

Original languageEnglish
Article numberncu350
Pages (from-to)38-41
Number of pages4
JournalRadiation Protection Dosimetry
Volume164
Issue number1-2
DOIs
Publication statusPublished - 1 Apr 2015

Bibliographical note

Funding Information:
The DoReMi Network of Excellence has received funding from the European Atomic Energy Community’s Seventh Framework Programme (FP7/ 2007-2011) under grant agreement no. 249689.

Publisher Copyright:
© The Author 2014.

Fingerprint

Dive into the research topics of 'European low-dose radiation risk research strategy: Future of research on biological effects at lowdoses'. Together they form a unique fingerprint.

Cite this